NASDAQ:PBM - Nasdaq - CA74449F2098 - Common Stock - Currency: USD
5.135
+0.17 (+3.53%)
The current stock price of PBM is 5.135 USD. In the past month the price increased by 3.32%. In the past year, price decreased by -97.24%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 18.74 | 339.94B | ||
AMGN | AMGEN INC | 14.22 | 158.77B | ||
GILD | GILEAD SCIENCES INC | 14.17 | 136.38B | ||
VRTX | VERTEX PHARMACEUTICALS INC | N/A | 120.40B | ||
REGN | REGENERON PHARMACEUTICALS | 12.81 | 61.30B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 41.07B | ||
ARGX | ARGENX SE - ADR | 97.43 | 34.21B | ||
BNTX | BIONTECH SE-ADR | N/A | 27.14B | ||
ONC | BEONE MEDICINES LTD-ADR | 6.39 | 27.09B | ||
NTRA | NATERA INC | N/A | 21.91B | ||
BIIB | BIOGEN INC | 8.48 | 19.67B | ||
INSM | INSMED INC | N/A | 18.63B |
Psyence Biomedical Ltd is a CA-based company operating in Biotechnology industry. The company is headquartered in Toronto, Ontario and currently employs 12 full-time employees. The company went IPO on 2021-12-10. Psyence Biomedical Ltd is a multi-asset, vertically integrated biopharmaceutical company specializing in psychedelic-based therapeutics. The firm is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. The company is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.
PSYENCE BIOMEDICAL LTD
121 Richmond Street West Penthouse, Suite 1300
TORONTO ONTARIO V6E 3Z3 CA
CEO: John Plourde
Employees: 12
Phone: 17744604171
The current stock price of PBM is 5.135 USD. The price increased by 3.53% in the last trading session.
The exchange symbol of PSYENCE BIOMEDICAL LTD is PBM and it is listed on the Nasdaq exchange.
PBM stock is listed on the Nasdaq exchange.
PSYENCE BIOMEDICAL LTD (PBM) has a market capitalization of 3.65M USD. This makes PBM a Nano Cap stock.
PSYENCE BIOMEDICAL LTD (PBM) currently has 12 employees.
PSYENCE BIOMEDICAL LTD (PBM) has a support level at 4.89 and a resistance level at 5.15. Check the full technical report for a detailed analysis of PBM support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
PBM does not pay a dividend.
The outstanding short interest for PSYENCE BIOMEDICAL LTD (PBM) is 2.64% of its float. Check the ownership tab for more information on the PBM short interest.
ChartMill assigns a technical rating of 3 / 10 to PBM. When comparing the yearly performance of all stocks, PBM is a bad performer in the overall market: 93.23% of all stocks are doing better.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | N/A |